Course Objectives: 

This symposium is intended for physicians, pharmacists, nurses and allied healthcare professionals who provide care to patients on anticoagulants such as warfarin, low molecular weight heparin, aspirin and other anti-thrombotic agents. 

Participants who attend this course should be able to: 

• Become aware of recently published, potentially practice-changing information relevant  to the diagnosis treatment or prevention of thromboembolism 

• Gain familiarity with the risks and benefits of adding anti-platelet therapy to chronic  warfarin 

• Appreciate the unique challenges associated with the prevention and treatment of  thromboembolic disease during pregnancy 

• Understand the need to adjust and or monitor certain anticoagulant therapies when  treating special populations (e.g. patients with obesity, renal insufficiency, etc).  

• Become familiar with the latest information relevant to making decisions about how long  a patient suffering VTE should be treated 

• Gain awareness of the advantages and limitations for various diagnostic strategies in  patients with suspected DVT or PE 

• Be introduced to novel anticoagulant agents currently in development 

• Learn the latest recommendations for the diagnosis and treatment of heparin-induced  thrombocytopenia 

• Explore the advantages and disadvantages of treating patients with PE entirely out-of- hospital 

• Be introduced to the Kaiser Permanente model of anticoagulant care 

• Take note of strategies available for the treatment of bleeding patients who have received  antithrombotic agents 

• Become familiar with the latest information relevant to weighing the risks and benefits of  anticoagulation for patients with atrial fibrillation 

• Understand the important relationship between cancer and venous thrombosis